The Tennessee Department of Health (TDH) is warning the public about a newly-identified synthetic opioid, cychlorphine, that ...

Lofexidine is administered during the period of peak withdrawal symptoms. The Food and Drug Administration (FDA) has approved Lofexidine Tablets 0.18mg, the first generic of Lucemyra. Lofexidine is a ...

Opioid use and abuse is a significant social, health and economic issue in Canada. Researchers at the University of Calgary's Faculty of Veterinary Medicine (UCVM) and Hotchkiss Brain Institute (HBI) ...

BXCL501 demonstrated clinical benefits and favorable tolerability profile for treatment of opioid withdrawal symptoms Results from this ...

EVERETT, Wash. — The Everett Fire Department’s Emergency Medical Services Division (EMS) has launched a new pilot programto allow paramedics to administer buprenorphine, to help with opiate withdrawal ...

Recovery from opiate addiction is not an easy path. For those attempting to stop, withdrawal symptoms can feel like a full-body rebellion; nausea and muscle aches, chills, anxiety, insomnia, and mood ...

Marijuana helps people with substance misuse disorders stay off opioids or reduce their use, maintain treatment, and manage withdrawal symptoms, a new federally funded study finds. Researchers at the ...

Health insurance loss, changes "may undermine continuity of critical treatment," researche ...

The device, which is cleared by the FDA for withdrawal mitigation from opioid use disorder, works by abating severe symptoms ...